Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

44.69 +3.60 (+8.76%)
Delayed Quote Updated: 11:45 AM EST, Nov 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vericel Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
MediWound Revenue Jumps 43% in Q2 ↗
Via The Motley Fool
News headline image
Vericel Corp (NASDAQ:VCEL): A High-Growth Stock with a Promising Technical Setup ↗
Vericel Corp (VCEL) is a high-growth biotech stock with strong fundamentals and a promising technical setup, making it a potential breakout candidate for investors. 
Via Chartmill
News headline image
Vericel Q2 Revenue Jumps 20% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Earnings Scheduled For July 31, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Where Vericel Stands With Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 27, 2025 ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About Vericel ↗
 
Via Benzinga
News headline image
Vericel Corp (NASDAQ: VCEL) Posts Mixed Q2 2025 Results with Revenue Miss and EPS Beat ↗
Vericel Corp (VCEL) posted mixed Q2 2025 results with revenue missing estimates but EPS beating expectations. Shares fell 6.5% pre-market despite strong MACI growth and margin expansion. 
Via Chartmill
News headline image
Vericel Reports Second Quarter 2025 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential ↗
VERICEL CORP (NASDAQ:VCEL) shows strong growth fundamentals and a technical breakout pattern, making it a stock to watch in the biotech sector. 
Via Chartmill
News headline image
Beyond The Numbers: 5 Analysts Discuss Vericel Stock ↗
 
Via Benzinga
News headline image
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential ↗
VERICEL CORP (NASDAQ:VCEL) shows strong revenue and earnings growth, backed by a solid balance sheet and a promising technical breakout pattern. 
Via Chartmill
News headline image
What Analysts Are Saying About Vericel Stock ↗
 
Via Benzinga
News headline image
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with a Technical Setup ↗
VERICEL CORP (NASDAQ:VCEL) shows strong growth potential with solid profitability and a promising technical setup, making it a stock worth watching. 
Via Chartmill
News headline image
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at Multiple Upcoming Investor Conferences
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
From Vericel Corporation
Via GlobeNewswire
News headline image
Vericel Stock Sees RS Rating Shoot Higher ↗
The Relative Strength (RS) Rating for Vericel stock entered a higher percentile Monday, as it got a lift from 69 to 79. 
Via Investor's Business Daily
News headline image
Smaller Cap Biotechs Are In Season: How Are We Doing? ↗
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
News headline image
Vericel Reports Third Quarter 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.